Two years after its approval by the Food and Drug Administration, opioid-overdose reversal product Rezenopy is about to make its…
Illinois is considering a wide-ranging harm reduction bill that advocates believe may have traction with legislators. If enacted, the Holistic…
On January 13 the Congressional Budget Office (CBO) released a report analyzing three policy approaches to the opioid-involved overdose crisis,…
In 2021, Harm Reduction Michigan (HRMI) began using streetside newspaper-style boxes to station naloxone kits in outdoor spaces where the…
The Food and Drug Administration is reportedly providing guidance and “positive feedback” for a proposed nalmefene product that will last…
Massachusetts is considering multiple proposals that, taken together, would make the landscape of overdose response increasingly hostile toward people who…
Less than two months after an investigation into deceptive marketing prompted Indivior Inc. to stop promoting its overdose antidote Opvee,…
Indivior PLC has discontinued marketing for Opvee, the opioid-overdose reversal product that the pharmaceutical company had claimed was more effective…
Indigenous people face persistent disparities in access to harm reduction services in the United States. In response, Native American health…
From New York City to rural Oklahoma and across the world, harm reduction vending machines are gaining popularity. They offer…